These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 3396009)
1. Increased adriamycin levels in hepatic implants of rabbit Vx-2 carcinoma from regional infusion. Ridge JA; Collin C; Bading JR; Hancock C; Conti PS; Daly JM; Raaf JH Cancer Res; 1988 Aug; 48(16):4584-7. PubMed ID: 3396009 [TBL] [Abstract][Full Text] [Related]
2. [Hepatic artery and portal vein infusion of adriamycin in experimental liver metastasis]. Kuroda K; Horita Y; Sakane M; Okumoto S; Katoh M; Saitoh Y Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2859-62. PubMed ID: 2782893 [TBL] [Abstract][Full Text] [Related]
3. [Comparative study on the comparative efficacy of hepatic arterial or portal venous infusion of adriamycin to control hepatic carcinoma growth]. Hoshino M; Koyama Y; Abe R Gan To Kagaku Ryoho; 1991 Aug; 18(11):1894-7. PubMed ID: 1877833 [TBL] [Abstract][Full Text] [Related]
4. [Enhanced effect of hepatic arterial infusion of anticancer drugs of rabbit VX-2 hepatic implants]. Koyama Y; Hoshino M; Ono T; Inoue N; Tsuchiya A; Abe R Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1721-4. PubMed ID: 2167643 [TBL] [Abstract][Full Text] [Related]
5. [Enhanced effect of hepatic arterial infused anticancer drugs on rabbit VX-2 carcinoma by means of combination with Lipiodol. Adriamycin versus Lipiodol adriamycin sandwich method and adriamycin suspended in a Lipiodol]. Hoshino M; Koyama Y; Sugano K; Kanno M; Satou N; Abe R Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2810-3. PubMed ID: 2551224 [TBL] [Abstract][Full Text] [Related]
6. Enhanced therapeutic effect against liver W256 carcinosarcoma with temperature-sensitive liposomal adriamycin administered into the hepatic artery. Zou Y; Yamagishi M; Horikoshi I; Ueno M; Gu X; Perez-Soler R Cancer Res; 1993 Jul; 53(13):3046-51. PubMed ID: 8319211 [TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetic comparison of intraarterial and intraportal infusion of adriamycin in regional chemotherapy of the liver]. Shiotani M; Ku Y; Kusunoki N; Kitagawa T; Maeda I; Tominaga M; Tanigawara Y; Kuroda Y; Saitoh Y Gan To Kagaku Ryoho; 1995 Sep; 22(11):1560-2. PubMed ID: 7574759 [TBL] [Abstract][Full Text] [Related]
8. Regional pharmacokinetics of doxorubicin following hepatic arterial and portal venous administration: evaluation with hepatic venous isolation and charcoal hemoperfusion. Iwasaki T; Ku Y; Kusunoki N; Tominaga M; Fukumoto T; Muramatsu S; Kuroda Y Cancer Res; 1998 Aug; 58(15):3339-43. PubMed ID: 9699664 [TBL] [Abstract][Full Text] [Related]
9. Tissue levels of chemotherapeutic agents for hepatic metastasis during hepatic arterial and portal injection. Kaneko A; Naomoto Y; Aoyama M; Tanaka N In Vivo; 1999; 13(2):195-8. PubMed ID: 10363178 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic and pharmacodynamic advantages of pirarubicin over adriamycin after intraarterial hepatic administration in the rabbit VX2 tumor model. Munck JN; Riggi M; Rougier P; Chabot GG; Ramirez LH; Zhao Z; Bognel C; Ardouin P; Herait P; Gouyette A Cancer Res; 1993 Apr; 53(7):1550-4. PubMed ID: 8453622 [TBL] [Abstract][Full Text] [Related]
11. Hepatic artery versus portal vein and systemic infusion of fluorodeoxyuridine of rabbit VX-2 hepatic implants. Butler JA; Trezona TP; Nordestgaard A; State D Am J Surg; 1989 Jan; 157(1):126-9. PubMed ID: 2521278 [TBL] [Abstract][Full Text] [Related]
12. New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer. Hong K; Khwaja A; Liapi E; Torbenson MS; Georgiades CS; Geschwind JF Clin Cancer Res; 2006 Apr; 12(8):2563-7. PubMed ID: 16638866 [TBL] [Abstract][Full Text] [Related]
13. Effects of verapamil and degradable starch microspheres during hepatic artery infusion of doxorubicin. Thom AK; Zhang SZ; Deveney C; Daly JM Surgery; 1990 May; 107(5):552-9. PubMed ID: 2333595 [TBL] [Abstract][Full Text] [Related]
14. [In vivo comparative study of the pharmacokinetics of chemotherapeutic agents infused via hepatic artery or portal vein against hepatic metastases. DRC Group]. Naomoto Y; Gochi A; Hizuta A; Iwagaki H; Matsuno T; Hamazaki K; Tanaka N; Orita K Gan To Kagaku Ryoho; 1993 Aug; 20(11):1555-8. PubMed ID: 8373217 [TBL] [Abstract][Full Text] [Related]
15. [Comparative study of the efficacy of hepatic arterial and portal venous infusion of adriamycin for prevention of liver metastases in rabbit VX2]. Koyama Y; Hoshino M; Igarashi W; Ono T; Hatakeyama Y; Abe R Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1540-3. PubMed ID: 1530303 [TBL] [Abstract][Full Text] [Related]
16. [Distribution of 5-FU in rat plasma and liver tissue after local 5-FU infusion]. Zheng JL; Liang LJ; Hu WJ; Shen SL Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):823-7. PubMed ID: 18504211 [TBL] [Abstract][Full Text] [Related]
17. [Experimental study on comparative efficacy of hepatic arterial injection of anticancer agent under temporary occlusion of portal vein]. Shirosaki I; Tazawa K; Kushibuchi T; Okamoto M; Yamagishi F; Bandou T; Shimoda M; Takemori S; Suzuki S; Yamashita Y Gan To Kagaku Ryoho; 1993 May; 20(7):937-9. PubMed ID: 8489299 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological evaluation of experimental isolated liver perfusion and hepatic artery infusion with 5-fluorouracil. de Brauw LM; Marinelli A; van de Velde CJ; Hermans J; Tjaden UR; Erkelens C; de Bruijn EA Cancer Res; 1991 Mar; 51(6):1694-700. PubMed ID: 1998960 [TBL] [Abstract][Full Text] [Related]
19. Tumor and liver drug uptake following hepatic artery and portal vein infusion. Sigurdson ER; Ridge JA; Kemeny N; Daly JM J Clin Oncol; 1987 Nov; 5(11):1836-40. PubMed ID: 3681370 [TBL] [Abstract][Full Text] [Related]
20. Potential advantages of loco-regional intra-arterial chemotherapy. Cagol PP; Pasqual E; Bacchetti S In Vivo; 2006; 20(6A):777-9. PubMed ID: 17203767 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]